Steven Coca
Nephrology · New York, NYNPI 1700972346
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $407,401 of the $444,753 with a category attached, or 91.6%. Renalytix AI, Inc. accounts for 69.1% of it on its own, with 10 other manufacturers making up the rest. Among nephrology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 142 payments — averaging $3132.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Renalytix AI, Inc.$307K
- AstraZeneca$42K
- Boehringer Ingelheim$31K
- Bayer$28K
- Nuwellis, Inc.$15K
- Vifor Pharma, Inc.$9K
- plus $12K from 5 others
What the payments were for
- Consulting fees$407,40192%
- Speaking & faculty fees$15,3183%
- Travel & lodging$17,6964%
- Food & beverage$4,3291%
- Education$100%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Renalytix AI, Inc. | 49 | $307,485 |
| AstraZeneca | 12 | $42,164 |
| Boehringer Ingelheim | 24 | $31,194 |
| Bayer | 32 | $27,812 |
| Nuwellis, Inc. | 8 | $15,100 |
| Vifor Pharma, Inc. | 8 | $9,128 |
| Boehringer Ingelheim International GmbH | 5 | $9,057 |
| Scpharmaceuticals Inc. | 1 | $1,200 |
| Fresenius USA Marketing, Inc. | 1 | $1,000 |
| Astrazeneca UK Limited | 1 | $490 |
| Amgen | 1 | $124 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- KIDNEYINTELX BLOOD COLLECTION CONVENIENCE KIT$301,671
- JARDIANCE$38,219
- Kerendia$25,832
- AQUADEX SMARTFLOW CONSOLE$10,600
- Veltassa$9,128
- ULTOMIRIS$9,097
- Aquadex$4,500
- Non-Covered$1,313
- FUROSCIX$1,200
- FARXIGA$490
- Repatha$124
How this compares
$444,753 in reported general payments places this provider in the 95th percentile of 935 nephrology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other nephrology in New York
- Gerald AppelNew York$842K
- Richard ChanNew York$514K
- Jai RadhakrishnanNew York$369K
- Girish NadkarniNew York$281K
- James ChevalierNew York$202K
- David CharytanNew York$164K
- Kirk CampbellNew York$152K
- Andrew BombackNew York$106K
- Alan PerlmanNew York$101K
- Phyllis AugustNew York$97K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.